BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 30245004)

  • 21. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.
    Hessol NA; Pipkin S; Schwarcz S; Cress RD; Bacchetti P; Scheer S
    Am J Epidemiol; 2007 May; 165(10):1143-53. PubMed ID: 17344204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pattern of secondary cancers in patients with Kaposi sarcoma in the United States.
    Kumar V; Garg M; Chaudhary N; Soni P; Floudas CS; Nwanyanwu C; Chandra A
    Cancer Causes Control; 2017 Oct; 28(10):1065-1074. PubMed ID: 28900786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States.
    Robbins HA; Shiels MS; Pfeiffer RM; Engels EA
    AIDS; 2014 Mar; 28(6):881-90. PubMed ID: 24300545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990.
    Koblin BA; Hessol NA; Zauber AG; Taylor PE; Buchbinder SP; Katz MH; Stevens CE
    Am J Epidemiol; 1996 Nov; 144(10):916-23. PubMed ID: 8916502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excess cancers among HIV-infected people in the United States.
    Robbins HA; Pfeiffer RM; Shiels MS; Li J; Hall HI; Engels EA
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
    Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
    Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
    Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
    AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer incidence in AIDS patients in Catalonia, Spain.
    Galceran J; Marcos-Gragera R; Soler M; Romaguera A; Ameijide A; Izquierdo A; Borràs J; de Sanjosé S; Casabona J
    Eur J Cancer; 2007 Apr; 43(6):1085-91. PubMed ID: 17349785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.
    Bower M; Palmieri C; Dhillon T
    Curr Opin Infect Dis; 2006 Feb; 19(1):14-9. PubMed ID: 16374212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.
    Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
    Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
    J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
    Shiels MS; Islam JY; Rosenberg PS; Hall HI; Jacobson E; Engels EA
    Ann Intern Med; 2018 Jun; 168(12):866-873. PubMed ID: 29801099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Record linkage to correct under-ascertainment of cancers in HIV cohorts: The Sinikithemba HIV clinic linkage project.
    Sengayi M; Spoerri A; Egger M; Kielkowski D; Crankshaw T; Cloete C; Giddy J; Bohlius J
    Int J Cancer; 2016 Sep; 139(6):1209-16. PubMed ID: 27098265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1.
    Rabkin CS; Yellin F
    J Natl Cancer Inst; 1994 Nov; 86(22):1711-6. PubMed ID: 7966400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy.
    van Leeuwen MT; Vajdic CM; Middleton MG; McDonald AM; Law M; Kaldor JM; Grulich AE
    AIDS; 2009 Oct; 23(16):2183-90. PubMed ID: 19734774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer incidence in people living with HIV/AIDS in Israel, 1981-2010.
    Zohar M; Micha B
    AIDS Res Hum Retroviruses; 2015 Sep; 31(9):873-81. PubMed ID: 25941873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of cancer among women with AIDS in New York City.
    Fordyce EJ; Wang Z; Kahn AR; Gallagher BK; Merlos I; Ly S; Schymura M; Chiasson MA
    AIDS Public Policy J; 2000; 15(3-4):95-104. PubMed ID: 12189715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer risk in elderly persons with HIV/AIDS.
    Biggar RJ; Kirby KA; Atkinson J; McNeel TS; Engels E;
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):861-8. PubMed ID: 15213571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001-2015.
    Horner MJ; Shiels MS; Pfeiffer RM; Engels EA
    Clin Infect Dis; 2021 May; 72(9):e224-e231. PubMed ID: 32710777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based surveillance of HIV-associated cancers: utility of cancer registry data.
    Clarke CA; Glaser SL
    J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1083-91. PubMed ID: 15247562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.